Nuclein Revenue and Competitors
Estimated Revenue & Valuation
- Nuclein's estimated annual revenue is currently $7.6M per year.
- Nuclein's estimated revenue per employee is $135,625
Employee Data
- Nuclein has 56 Employees.
- Nuclein grew their employee count by 33% last year.
Nuclein's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Scientist | Reveal Email/Phone |
2 | CEO | Reveal Email/Phone |
3 | Controller | Reveal Email/Phone |
4 | Director Software Engineering | Reveal Email/Phone |
5 | Associate Director, Quality | Reveal Email/Phone |
6 | Chief People Officer | Reveal Email/Phone |
7 | Regional Sales Manager | Reveal Email/Phone |
8 | Senior Software Engineering Manager | Reveal Email/Phone |
9 | Assay Development Manager | Reveal Email/Phone |
10 | Product Development Manager | Reveal Email/Phone |
Nuclein Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 13 | 44% | N/A | N/A |
#2 | $14.9M | 73 | -8% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 5 | -37% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 51 | 31% | N/A | N/A |
#8 | $0.8M | 5 | 25% | N/A | N/A |
#9 | $1.6M | 9 | 13% | N/A | N/A |
#10 | $16.3M | 80 | -9% | N/A | N/A |
What Is Nuclein?
Nuclein, LLC was founded in 2017 by experienced biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's mission is to create a hand-held, disposable, all-in-one, self-test for infectious disease testing, which delivers battery-powered, sample-to-answer results within one hour, without the need to mail in a sample. The company is headquartered in Austin, Texas.
keywords:N/AN/A
Total Funding
56
Number of Employees
$7.6M
Revenue (est)
33%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $10.2M | 56 | 8% | N/A |
#2 | $7.3M | 56 | 8% | N/A |
#3 | $17.1M | 56 | 0% | N/A |
#4 | $11.5M | 56 | 12% | N/A |
#5 | $7.1M | 56 | N/A | N/A |